on Wednesday appointed Robert Ross as Chief Financial Officer, starting 1st January, 2020.
Robert is Finance Director of transport and logistics company Europa Worldwide Group, which brought in annual revenues in excess of £175 million, Xpediator said.
Robert led the finance division of Europa from November 2015, responsible for M&A processes, facilities, refinancing and restructuring of the finance function, as well as leading HR and talent acquisition.
Xpediator also noted that before Europa, Robert held management roles at PwC specialising in Retail, Leisure and Consumer sectors, working with Private Equity houses for buy and sell side assignments.
Shares ticked up 1.64% higher to 31p during Wednesday trading
Stephen Blyth, Chief Executive Officer of Xpediator, commented: "I am delighted Robert is joining us. He is a talented individual and comes to us from an industry peer of a similar size which ensures he has an excellent understanding of our markets and the future opportunities within them.”
He added: “Xpediator has grown substantially over the past three years and we have an ambitious growth strategy in which Robert will be centrally involved. I am also very pleased we are able to retain Richard in a key central role within the Group to which he is ideally suited."
The appointment comes a week after Xpediator appointed two new senior logistics executives, Wim Pauwels, formerly of Yusen Logistics Europe and Sony, and Charles McGurin formerly of Allport Cargo Services Group and DHL, as Non-Executive Directors on 4 November.
Current interim Chief Financial Officer will become Chief Commercial Officer and join Xpediator’s Operating Board.
Follow News & Updates from Xpediator here:
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
- SP Angel . Morning View . Trade deal optimism and UK election results lift markets
13th Dec 2019SP Angel research note on commodities and miners, featuring: Ferro-Alloy Resources Limited (FAR LN) – Fall in vanadium pentoxide price prompts management to look for new funding Resolute Mining (RSG LN) – Bibiani review Sirius Minerals (SXX LN) – A Siriusly sorry Christmas Carol Vast Resources* (VAST LN) 0.29p, Mkt Cap £29m – Exposure to copper and rough diamonds in Romania and Zimbabwe
- Xtract Resources, Russ Mould, Alan Green
13th Dec 2019Colin Bird Executive Chairman of Xtract Resources (XTR) talks about the Alluvial Collaboration Agreement with Nexus and provides a general update Russ Mould, Investment Director at stockbroker AJ Bell talks about: the Election Result, Macro and UK stocks Alan Green talks about 4 stocks
- Horizon Discovery Group enters collaboration with Mammoth Biosciences
Abraham DarwyneCompany News - 2 mins13th Dec 2019Mammoth Biosciences is a US-based biotech company that developed the world's first CRISPR-based detection platform capable of sensing any biomarker or disease with DNA/RNA backed by investors that include Mayfield, NFX, 8VC, AME Cloud, Wireframe, Kairos, along with Tim Cook, Brook Byers, Bob Nelsen, and Jeff Huber.
- Savannah Petroleum renews €11.4 million loan facility with Oragroup
13th Dec 2019“It has given us substantial financial flexibility at a highly competitive rate of interest in the last three years as we have successfully carried out our multi-well Niger drilling campaign and completed the Seven Energy transaction."
- Q&A with Immupharma (IMM) Chairman Tim McCarthy
13th Dec 2019Tim McCarthy, Chairman of ImmuPharma (IMM) discusses the deal with US-based Avion Pharmaceuticals, the agreement with Lanstead Capital and what the future holds for ImmuPharma regarding new trial design as well as anticipated upcoming milestones.
- Morning Financial Press Review 13/12/19
13th Dec 2019The hedge fund owned by the billionaire investor and anti-Brexit donor George Soros has made a £16m bet against shares in the owner of the Daily Mail newspaper, Ocado has said its product range will be 50% bigger and offer lower prices and better quality products when it switches from Waitrose to Marks & Spencer next year,
- SP Angel . Morning View . Equities climb as Fed signals stable rates through 2020
12th Dec 2019SPAngel research note on commodities and miners, featuring: Base Resources (BSE LN) – Toliara DFS confirms PFS estimates Premier African Minerals* (PREM LN) – Fundraising Resolute Mining (RSG LN) – Drilling results from Tabakoroni
